UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+10.85%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.16B
AUM Growth
-$2.43B
(-44%)
Cap. Flow
-$2.83B
Cap. Flow
% of AUM
-89.49%
Top 10 Holdings %
Top 10 Hldgs %
61.23%
Holding
616
New
86
Increased
50
Reduced
239
Closed
136
Top Buys
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$579M |
| 2 |
SPLK
Splunk Inc
SPLK
|
$454M |
| 3 |
HES
Hess
HES
|
$334M |
| 4 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
$120M |
| 5 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$73.1M |
Top Sells
Sector Composition
| 1 | Energy | 29.73% |
| 2 | Technology | 22.08% |
| 3 | Healthcare | 10.58% |
| 4 | Real Estate | 7.31% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTS
251
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $984K | 0.03% |
1,180,000
+980,000
| +490% | +$817K |
|
252
HilleVax
HLVX
$105M
| $980K | 0.03% |
61,059
-53,419
| -47% | -$857K |
|
|
VRNA
253
Verona Pharma
VRNA
$9.2B
| $965K | 0.03% |
48,533
-39,095
| -45% | -$777K |
|
|
RVNC
254
DELISTED
Revance Therapeutics, Inc.
RVNC
| $964K | 0.03% |
109,667
+20,867
| +23% | +$183K |
|
255
Axsome Therapeutics
AXSM
$6.25B
| $949K | 0.03% |
11,922
-13,813
| -54% | -$1.1M |
|
256
Teva Pharmaceuticals
TEVA
$21.7B
| $940K | 0.03% |
90,017
-94,983
| -51% | -$992K |
|
257
Axogen
AXGN
$735M
| $940K | 0.03% |
137,575
-101,621
| -42% | -$694K |
|
258
JD.com
JD
$44.6B
| $939K | 0.03% |
+32,500
| New | +$939K |
|
259
Wyndham Hotels & Resorts
WH
$6.59B
| $919K | 0.03% |
11,428
-160,443
| -93% | -$12.9M |
|
260
Immunic
IMUX
$75.1M
| $900K | 0.03% |
600,234
-161,453
| -21% | -$242K |
|
|
SILK
261
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $890K | 0.03% |
72,556
+26,028
| +56% | +$319K |
|
262
Meta Platforms (Facebook)
META
$1.89T
| $885K | 0.03% |
2,500
-5,000
| -67% | -$1.77M |
|
263
89bio
ETNB
$1.32B
| $883K | 0.03% |
79,075
-19,763
| -20% | -$221K |
|
|
TRIS
264
DELISTED
Tristar Acquisition I Corp.
TRIS
| $870K | 0.03% |
80,656
-36,254
| -31% | -$391K |
|
265
Sun Communities
SUI
$16.2B
| $853K | 0.03% |
6,379
-40,122
| -86% | -$5.36M |
|
266
Iovance Biotherapeutics
IOVA
$901M
| $846K | 0.03% |
104,059
-137,915
| -57% | -$1.12M |
|
267
Replimune Group
REPL
$494M
| $843K | 0.03% |
+100,000
| New | +$843K |
|
268
Cloudflare
NET
$74.7B
| $833K | 0.03% |
10,000
-35,000
| -78% | -$2.91M |
|
269
Savara
SVRA
$643M
| $831K | 0.03% |
176,886
-203,466
| -53% | -$956K |
|
|
BPMC
270
DELISTED
Blueprint Medicines
BPMC
| $830K | 0.03% |
9,000
-39,984
| -82% | -$3.69M |
|
271
California Resources
CRC
$4.1B
| $827K | 0.03% |
15,119
-1,529
| -9% | -$83.6K |
|
272
Procept Biorobotics
PRCT
$2.26B
| $826K | 0.03% |
19,717
-15,399
| -44% | -$645K |
|
273
Freshworks
FRSH
$3.74B
| $822K | 0.03% |
+35,000
| New | +$822K |
|
274
Adaptive Biotechnologies
ADPT
$1.96B
| $812K | 0.03% |
165,745
-35,595
| -18% | -$174K |
|
275
Aura Biosciences
AURA
$403M
| $797K | 0.03% |
90,000
+46,000
| +105% | +$408K |
|